Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs IV Amantadine for Hemodynamic Response to Intubation
NCT03612921Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Aug 2018
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amantadine in hemodynamic instability (3 arms), sponsored by Assiut University. Primary endpoint: Effect of amantadine on beta-endorphin levels. Status: unknown.
02
Drugs
amantadine
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT03612921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03612921.